Equity Overview
Price & Market Data
Price: $27.37
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $1,201,302,144
Daily Volume: 0
Performance Metrics
1 Week: 11.21%
1 Month: 19.57%
3 Months: -19.97%
6 Months: -14.89%
1 Year: 281.5%
YTD: -8.98%
Company Details
Employees: 27
Sector: Health technology
Industry: Medical specialties
Country: Germany
Details
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.